Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/8248
|
| Title: | Effect of the use of low and high potency statins and sepsis outcomes |
| Authors: | Ou, SY;Chu, H;Chao, PW;Ou, SM;Lee, YJ;Kuo, SC;Li, SY;Shih, CJ;Chen, YT |
| Contributors: | Division of Infectious Diseases |
| Abstract: | Introduction Although statins have been shown to have cholesterol-lowering effects, their pleiotropic benefits on sepsis remain a matter of debate. In addition, the influence of statin potency on sepsis-related mortality has never been explored. The aim of our study was to determine the sepsis outcomes of low- and high-potency statin users and non-users. Methods This nationwide, population-based, propensity score-matched analysis used data from the linked administrative databases of Taiwan's National Health Insurance program. Patients were hospitalized for sepsis between 2000 and 2010. All-cause mortality and major adverse consequences of sepsis, such as in-hospital death, intensive care unit admission, shock events, and the use of mechanical ventilation, were assessed. Patients were divided into high-potency statin users (at least 10 mg rosuvastatin, at least 20 mg atorvastatin, or at least 40 mg simvastatin), low-potency statin users (all other statin treatments), and non-users. Results A propensity score-matched cohort of 27,792 statin users and 27,792 non-users was included. Of 27,792 statin users, 9,785 (35.2 %) were treated with high-potency statins and 18,007 (64.8 %) were treated with low-potency statins. The 1-year mortality risk was significantly lower among both low-potency [adjusted hazard ratio (aHR) 0.89, 95 % confidence interval (CI) 0.85-0.93] and high-potency (aHR 0.80, 95 % CI 0.75-0.86) statin users compared with non-users. The risks of mortality and adverse consequences of sepsis were lower among high-potency than among low-potency statin users. Conclusions High-potency statin use is associated with a lower risk of sepsis-related mortality compared with low-potency statin use. |
| Date: | 2014-10 |
| Relation: | Intensive Care Medicine. 2014 Oct;40(10):1509-1517. |
| Link to: | http://dx.doi.org/10.1007/s00134-014-3418-1 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0342-4642&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000342433000011 |
| Cited Times(Scopus): | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84919400003 |
| Appears in Collections: | [郭書辰] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| SCP84905308066.pdf | | 327Kb | Adobe PDF | 400 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
